Hims & Hers Health, Inc.

NYSE:HIMS

20.76 (USD) • At close November 4, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Revenue 315.648278.171246.619226.699207.912190.77167.203144.836113.563101.31484.69974.17360.69252.31441.46641.32435.90430.06324.76921.68418.05318.053
Cost of Revenue 100.48849.07645.21939.39137.75437.34534.86630.38326.38726.55822.60119.30113.41512.0679.57410.04710.2429.4449.6389.4359.449.44
Gross Profit 215.16229.095201.4187.308170.158153.425132.337114.45387.17674.75662.09854.87247.27740.24731.89231.27725.66220.61915.13112.2498.6138.613
Gross Profit Ratio 0.6820.8240.8170.8260.8180.8040.7910.790.7680.7380.7330.740.7790.7690.7690.7570.7150.6860.6110.5650.4770.477
Reseach & Development Expenses 18.65415.32413.40512.2711.80410.7488.3117.9776.8616.0885.5726.2420000000000
General & Administrative Expenses 40.55434.56832.31935.90731.14430.51327.56847.99746.87643.58240.95644.2436.7461.69817.20419.49614.84114.06415.49217.65711.35711.357
Selling & Marketing Expenses 144.922130.553125.895116.076107.21997.24585.54278.46260.4948.09342.70738.29327.94426.95819.31415.10211.812.77313.17314.11517.93417.934
SG&A 184.847165.121210.124151.983138.363127.758113.11126.459107.36691.67583.66382.53364.68488.65636.51834.59826.64126.83728.66531.77229.29129.291
Other Expenses 2.3942.52.5961.6382.06626.18222.5210.6770.4020.320.1250.2190.325-2.905-0.5790.0080.0560.230.283000
Operating Expenses 203.501219.192210.124195.862179.394164.688143.942134.436107.36691.67583.66382.53364.68488.65636.51834.59826.64126.83728.66531.48829.40729.407
Operating Income 11.6599.903-8.724-8.554-9.236-11.263-11.605-19.983-20.19-16.919-21.565-27.661-17.407-48.409-4.626-3.321-0.979-6.218-13.534-19.523-20.679-20.679
Operating Income Ratio 0.0370.036-0.035-0.038-0.044-0.059-0.069-0.138-0.178-0.167-0.255-0.373-0.287-0.925-0.112-0.08-0.027-0.207-0.546-0.9-1.145-1.145
Total Other Income Expenses Net 1.7652.510.921.6382.0661.5820.5771.1270.5230.761-9.6838.5478.288-2.905-0.579-2.5190.0350.231.2340.880.180.18
Income Before Tax 13.42412.4032.196-6.916-7.17-9.681-11.028-18.856-19.667-16.158-31.248-19.114-9.119-51.314-5.205-5.84-0.944-5.998-12.333-18.643-20.499-20.499
Income Before Tax Ratio 0.0430.0450.009-0.031-0.034-0.051-0.066-0.13-0.173-0.159-0.369-0.258-0.15-0.981-0.126-0.141-0.026-0.2-0.498-0.86-1.136-1.136
Income Tax Expense 0.1271.2750.9510.651-0.0130.386-0.121-0.0160.0120.094-0.087-3.1730.0340.090.0240.0310.0370.0350.0230.0220.0230.023
Net Income 13.29711.1281.245-7.567-7.157-10.067-10.907-18.84-19.679-16.252-31.161-15.941-9.153-51.404-5.229-5.871-0.981-6.033-12.356-18.665-20.522-20.522
Net Income Ratio 0.0420.040.005-0.033-0.034-0.053-0.065-0.13-0.173-0.16-0.368-0.215-0.151-0.983-0.126-0.142-0.027-0.201-0.499-0.861-1.137-1.137
EPS 0.0620.050.006-0.036-0.034-0.049-0.053-0.092-0.097-0.08-0.15-0.08-0.048-0.34-0.066-0.16-0.028-0.17-0.36-0.24-0.27-0.27
EPS Diluted 0.0570.050.006-0.036-0.034-0.049-0.053-0.092-0.097-0.08-0.15-0.08-0.048-0.34-0.066-0.16-0.028-0.17-0.36-0.24-0.27-0.27
EBITDA 15.30212.904-6.066-6.191-6.859-9.146-11.605-18.531-18.49-15.619-21.44-25.896-16.577-50.92-4.626-3.013-0.711-5.808-12.15-19.428-20.671-20.671
EBITDA Ratio 0.0480.046-0.025-0.027-0.033-0.048-0.069-0.128-0.163-0.154-0.253-0.349-0.273-0.973-0.112-0.073-0.02-0.193-0.491-0.896-1.145-1.145